CN111529468A - 一种补水保湿的面膜精华液及其制备方法 - Google Patents
一种补水保湿的面膜精华液及其制备方法 Download PDFInfo
- Publication number
- CN111529468A CN111529468A CN202010489049.3A CN202010489049A CN111529468A CN 111529468 A CN111529468 A CN 111529468A CN 202010489049 A CN202010489049 A CN 202010489049A CN 111529468 A CN111529468 A CN 111529468A
- Authority
- CN
- China
- Prior art keywords
- extract
- root extract
- skin
- mask essence
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000000284 extract Substances 0.000 claims abstract description 118
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 63
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 30
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 28
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 26
- 229960001631 carbomer Drugs 0.000 claims abstract description 26
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 26
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000002994 raw material Substances 0.000 claims abstract description 24
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 23
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical compound C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 23
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 23
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 23
- 229910003472 fullerene Inorganic materials 0.000 claims abstract description 23
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 23
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 23
- 235000015099 wheat brans Nutrition 0.000 claims abstract description 21
- 244000075850 Avena orientalis Species 0.000 claims abstract description 20
- 235000007319 Avena orientalis Nutrition 0.000 claims abstract description 20
- 229940059958 centella asiatica extract Drugs 0.000 claims abstract description 20
- 150000004702 methyl esters Chemical class 0.000 claims abstract description 20
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims abstract description 19
- 240000001341 Reynoutria japonica Species 0.000 claims abstract description 18
- 235000018167 Reynoutria japonica Nutrition 0.000 claims abstract description 18
- 240000004534 Scutellaria baicalensis Species 0.000 claims abstract description 18
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims abstract description 18
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims abstract description 18
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims abstract description 14
- 244000234609 Portulaca oleracea Species 0.000 claims abstract description 13
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 13
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 11
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 9
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 9
- 235000011477 liquorice Nutrition 0.000 claims abstract description 8
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims abstract description 3
- 241000628997 Flos Species 0.000 claims abstract description 3
- 244000042664 Matricaria chamomilla Species 0.000 claims abstract description 3
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims abstract description 3
- RGUVUPQQFXCJFC-UHFFFAOYSA-N n-hydroxyoctanamide Chemical compound CCCCCCCC(=O)NO RGUVUPQQFXCJFC-UHFFFAOYSA-N 0.000 claims abstract description 3
- 238000003756 stirring Methods 0.000 claims description 21
- 240000008632 Cota tinctoria Species 0.000 claims description 17
- 239000002253 acid Substances 0.000 claims description 17
- 235000020221 chamomile extract Nutrition 0.000 claims description 17
- 229940119217 chamomile extract Drugs 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 16
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 claims description 15
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 15
- 230000001815 facial effect Effects 0.000 claims description 14
- 229940069445 licorice extract Drugs 0.000 claims description 12
- 229940087068 glyceryl caprylate Drugs 0.000 claims description 11
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 claims description 11
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- 229940064064 purslane extract Drugs 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 6
- 238000003860 storage Methods 0.000 claims description 6
- 230000001965 increasing effect Effects 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 244000005700 microbiome Species 0.000 claims description 4
- 238000012371 Aseptic Filling Methods 0.000 claims description 3
- 238000009455 aseptic packaging Methods 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 230000000249 desinfective effect Effects 0.000 claims description 3
- 238000001514 detection method Methods 0.000 claims description 3
- 238000007599 discharging Methods 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 230000000813 microbial effect Effects 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000005070 sampling Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 229960004418 trolamine Drugs 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 230000037303 wrinkles Effects 0.000 abstract description 6
- 235000015097 nutrients Nutrition 0.000 abstract description 3
- 208000002874 Acne Vulgaris Diseases 0.000 abstract description 2
- 206010000496 acne Diseases 0.000 abstract description 2
- 230000007812 deficiency Effects 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- 230000036620 skin dryness Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 37
- 230000000694 effects Effects 0.000 description 19
- 239000002537 cosmetic Substances 0.000 description 9
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 244000153955 Reynoutria sachalinensis Species 0.000 description 4
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 210000004207 dermis Anatomy 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 235000005152 nicotinamide Nutrition 0.000 description 4
- 239000011570 nicotinamide Substances 0.000 description 4
- 229960003966 nicotinamide Drugs 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 230000002087 whitening effect Effects 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 3
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 3
- 230000003385 bacteriostatic effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 150000002212 flavone derivatives Chemical class 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 235000021283 resveratrol Nutrition 0.000 description 3
- 229940016667 resveratrol Drugs 0.000 description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 3
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 239000010282 Emodin Substances 0.000 description 2
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000004378 Glycyrrhizin Substances 0.000 description 2
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 2
- 229930194248 Licoflavone Natural products 0.000 description 2
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 2
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- VCNKUCWWHVTTBY-UHFFFAOYSA-N 18alpha-Oleanane Natural products C1CCC(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4CCC3C21C VCNKUCWWHVTTBY-UHFFFAOYSA-N 0.000 description 1
- YEDFEBOUHSBQBT-UHFFFAOYSA-N 2,3-dihydroflavon-3-ol Chemical compound O1C2=CC=CC=C2C(=O)C(O)C1C1=CC=CC=C1 YEDFEBOUHSBQBT-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- 241000561734 Celosia cristata Species 0.000 description 1
- 244000146462 Centella asiatica Species 0.000 description 1
- 235000004032 Centella asiatica Nutrition 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 241001278898 Glycyrrhiza inflata Species 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- FURUXTVZLHCCNA-UHFFFAOYSA-N Liquiritigenin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-UHFFFAOYSA-N 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 1
- BNMGUJRJUUDLHW-HCZMHFOYSA-N Madecassoside Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(C[C@@H](O)[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O BNMGUJRJUUDLHW-HCZMHFOYSA-N 0.000 description 1
- BNMGUJRJUUDLHW-HLUHVYOBSA-N Madecassoside Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5[C@H](O)C[C@@]34C)[C@@H]2[C@H]1C)C(=O)O[C@@H]6O[C@H](CO[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O BNMGUJRJUUDLHW-HLUHVYOBSA-N 0.000 description 1
- 241001446467 Mama Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241001085205 Prenanthella exigua Species 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 1
- 206010058679 Skin oedema Diseases 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- 241000159241 Toxicodendron Species 0.000 description 1
- 241000159243 Toxicodendron radicans Species 0.000 description 1
- 241000871311 Toxicodendron vernix Species 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 1
- 229940022757 asiaticoside Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000036996 cardiovascular health Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 210000001520 comb Anatomy 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000490 cosmetic additive Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 150000002208 flavanones Chemical class 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 229930003939 flavanonol Natural products 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000007946 flavonol Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229940072008 glycyrrhiza glabra extract Drugs 0.000 description 1
- -1 glycyrrhiza polysaccharide Chemical class 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical class C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 1
- SIOMFBXUIJKTMF-UHFFFAOYSA-N hypoglauterpenic acid Natural products C1CC(O)C(C)(C)C2=CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C SIOMFBXUIJKTMF-UHFFFAOYSA-N 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- NNQSGBRGJHSRFN-UHFFFAOYSA-N isoflavan Chemical compound C1OC2=CC=CC=C2CC1C1=CC=CC=C1 NNQSGBRGJHSRFN-UHFFFAOYSA-N 0.000 description 1
- 235000002324 isoflavanes Nutrition 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 235000008718 isoliquiritigenin Nutrition 0.000 description 1
- DXDRHHKMWQZJHT-FPYGCLRLSA-N isoliquiritigenin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O DXDRHHKMWQZJHT-FPYGCLRLSA-N 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- FURUXTVZLHCCNA-AWEZNQCLSA-N liquiritigenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-AWEZNQCLSA-N 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 229940090813 madecassoside Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000002464 muscle smooth vascular Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 125000000627 niacin group Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- BPAWXSVOAOLSRP-UHFFFAOYSA-N oleanane Natural products CCCCCCCCCCCCCCCC(=O)OC1CCC2(C)C(CCC3(C)C2CC=C4C5CC(C)(C)CCC5(C)C(O)CC34C)C1(C)C BPAWXSVOAOLSRP-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229940056692 resinol Drugs 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 229940126672 traditional medicines Drugs 0.000 description 1
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 229920006337 unsaturated polyester resin Polymers 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种补水保湿的面膜精华液及其制备方法，包括以下百分比的原料：甲酯0.1‑1％、丙二醇8‑12％、透明质酸钠5‑10％、卡波姆5‑10％、水50‑70％、丁二醇5‑10％、富勒烯4‑6％、海藻糖3‑5％、烟酰胺1‑4％、辛酰羟肟酸0.05‑1％、三乙醇胺0.05‑0.2％、甘油辛酸酯0.05‑1％、积雪草提取物0.05‑1％、马齿笕提取物0.05‑1％、燕麦仁提取物0.05‑1％、小麦麸提取物0.05‑1％、光果甘草根提取物0.05‑1％、金黄洋甘菊提取物0.05‑1％、甘草提取物0.05‑1％、虎杖根提取物0.05‑1％、黄岑根提取物0.05‑1％。有益效果在于：精华液内的营养成分渗透肌肤后，被肌肤吸收，可以重现水润肌肤，配合保湿补水成分，为肌肤补充水份，舒润、修护、保湿呵护肌肤，改善肌肤缺水干燥现象，长期使用可以令肌肤玉润清透，舒缓补水，抗皱嫩肤，控油祛痘，亮泽水润。
Description
技术领域
本发明涉及化妆品技术领域，特别是涉及一种补水保湿的面膜精华液及其制备方法。
背景技术
随着生活水平的提高，人们越来越重视皮肤护理，希望通过使用化妆品达到肌肤保湿、延缓衰老的效果。面膜是广大女性常用的一种护肤品，随着社会的发展，环境的破坏，紫外线、空调、风沙、过度洗浴等都会造成皮肤干燥；另外自身的年龄增加、皮脂分泌不足、压力大、疲劳等也会造成皮肤干燥。现有的营养面膜、中药面膜多种多样，功能各异，但是这些面膜或是添加有各种化学药品，虽然见效快，但是依赖性强，停用后皮肤变得比以前更糟，皮肤自我修复功能下降；或是各种祛斑、美白、抗衰老等功能性面膜，基础的补水保湿中药面膜不多，而且效果不佳。
发明内容
本发明的目的就在于为了解决上述问题而提供一种补水保湿的面膜精华液及其制备方法。
本发明通过以下技术方案来实现上述目的：
一种补水保湿的面膜精华液，包括以下百分比的原料：甲酯0.1-1％、丙二醇8-12％、透明质酸钠5-10％、卡波姆5-10％、水50-70％、丁二醇5-10％、富勒烯4-6％、海藻糖3-5％、烟酰胺1-4％、辛酰羟肟酸0.05-1％、三乙醇胺0.05-0.2％、甘油辛酸酯0.05-1％、积雪草提取物0.05-1％、马齿笕提取物0.05-1％、燕麦仁提取物0.05-1％、小麦麸提取物0.05-1％、光果甘草根提取物0.05-1％、金黄洋甘菊提取物0.05-1％、甘草提取物0.05-1％、虎杖根提取物0.05-1％、黄岑根提取物0.05-1％。
进一步的，由如下重量份配比的原材料组成：甲酯0.1％、丙二醇10％、透明质酸钠7.62％、卡波姆6.5％、水55％、丁二醇7％、富勒烯5％、海藻糖3.8％、烟酰胺2.9％、辛酰羟肟酸0.1％、三乙醇胺0.08％、甘油辛酸酯0.1％、积雪草提取物0.2％、马齿笕提取物0.2％、燕麦仁提取物0.2％、小麦麸提取物0.2％、光果甘草根提取物0.2％、金黄洋甘菊提取物0.2％、甘草提取物0.2％、虎杖根提取物0.2％、黄岑根提取物0.2％。
进一步的，由如下重量份配比的原材料组成：甲酯0.56％、丙二醇8％、透明质酸钠8.12％、卡波姆8％、水50％、丁二醇6.5％、富勒烯5.67％、海藻糖4.6％、烟酰胺3.24％、辛酰羟肟酸0.5％、三乙醇胺0.05％、甘油辛酸酯0.26％、积雪草提取物0.5％、马齿笕提取物0.5％、燕麦仁提取物0.5％、小麦麸提取物0.5％、光果甘草根提取物0.5％、金黄洋甘菊提取物0.5％、甘草提取物0.5％、虎杖根提取物0.5％、黄岑根提取物0.5％。
进一步的，由如下重量份配比的原材料组成：甲酯0.3％、丙二醇11％、透明质酸钠5.07％、卡波姆5％、水63％、丁二醇5％、富勒烯4％、海藻糖3.2％、烟酰胺1.8％、辛酰羟肟酸0.3％、三乙醇胺0.13％、甘油辛酸酯0.3％、积雪草提取物0.1％、马齿笕提取物0.1％、燕麦仁提取物0.1％、小麦麸提取物0.1％、光果甘草根提取物0.1％、金黄洋甘菊提取物0.1％、甘草提取物0.1％、虎杖根提取物0.1％、黄岑根提取物0.1％。
进一步的，包括以下百分比的原料：甲酯0.2％、丙二醇9％、透明质酸钠6.34％、卡波姆7.22％、水60％、丁二醇5.4％、富勒烯4.23％、海藻糖3.0％、烟酰胺1.2％、辛酰羟肟酸0.2％、三乙醇胺0.18％、甘油辛酸酯0.33％、积雪草提取物0.3％、马齿笕提取物0.3％、燕麦仁提取物0.3％、小麦麸提取物0.3％、光果甘草根提取物0.3％、金黄洋甘菊提取物0.3％、甘草提取物0.3％、虎杖根提取物0.3％、黄岑根提取物0.3％。
本发明还提供一种制备上述补水保湿的面膜精华液的制备方法，包括如下步骤：
步骤一，按照预先设置好的重量百分比称取各原料，然后将生产用的搅拌锅清洗、消毒后晾干；
步骤二，将水、丁二醇、富勒烯、海藻糖依次加入搅拌锅内，开始搅拌加热，待其溶解完全，得到溶液一；
步骤三，将透明质酸钠、卡波姆加入步骤二得到的溶液一中，待其溶解完全，得到溶液二；
步骤四，将甲酯、丙二醇在30-35℃下混合搅拌均匀，得到溶液三；
步骤五，将步骤三得到的溶液二加热，在其温度为58-60℃时将步骤四得到的溶液三加入其中，持续升温并进行搅拌，当升温到80-85℃后开始保持恒温，30分钟后开始降温，得到溶液四；
步骤六，当溶液四温度降低到43-47℃时，将烟酰胺、辛酰羟肟酸、三乙醇胺、甘油辛酸酯、积雪草提取物、马齿笕提取物、燕麦仁提取物、小麦麸提取物、光果甘草根提取物、金黄洋甘菊提取物、甘草提取物、虎杖根提取物、黄岑根提取物加入其中，搅拌均匀，得到溶液五；
步骤七，溶液五继续降温，当温度降低到38℃时过滤出料；
步骤八，对物料进行抽样检测，检测合格后管装入洁净、无菌的储存罐中密封；
步骤九，将盛放物料的储存罐转入静置室内静置，然后进行微生物检测；
步骤十，微生物检测合格后进行无菌灌装、包装、入库。
进一步的，所述步骤六中，搅拌时间不小于30分钟。
进一步的，所述步骤九中，静置时间2-6h。
其中，本发明所采用的原料组份阐述如下：
甲酯：甲酯又称脂肪酸甲酯，是用途广泛的表面活性剂(SAA)的原料；
丙二醇：丙二醇与水、乙醇及多种有机溶剂混溶。丙二醇可用作不饱和聚酯树脂的原料，在化妆品、牙膏和香皂中可与甘油或山梨醇配合用作润湿剂，在染发剂中用作调湿、匀发剂，也用作防冻剂，还用于玻璃纸、增塑剂和制药工业，牙膏中也有添加丙二醇的；
透明质酸钠：透明质酸钠为从鸡冠中提取的物质，也可通过乳酸球菌发酵制得，为白色或类白色颗粒或粉末，无臭味，干燥时，氮含量为2.8％-4.0％，葡糖醛酸含量为37.0％-51.0％，在化妆品领域中使用较多，能起到独特的保护皮肤作用，可保持皮肤滋润光滑，细腻柔嫩，富有弹性，具有防皱、抗皱、美容保健和恢复皮肤生理功能的作用；
卡波姆：卡波姆也称卡波，是以季戊四醇等与丙烯酸交联得到的丙烯酸交联树脂，是一类非常重要的流变调节剂，中和后的卡波是优秀的凝胶基质，有增稠悬浮等重要用途，工艺简单，稳定性好，广泛应用于乳液、膏霜、凝胶中；
丁二醇：在化妆品中常做保湿剂和溶剂使用，在保湿方面，由于丁二醇是小分子保湿成份，所以抓水比例很小，同时也有一定的抑菌作用；
富勒烯：富勒烯能够亲和自由基，具有极强的抗氧化能力，能够起到活化皮肤细胞，预防肌肤衰亡的作用；
海藻糖：海藻糖分子量小，易于被皮肤吸收，进入细胞内发挥其独特的水替代应激因子作用和保护细胞膜的功能，提高细胞的抗干燥、抗冷冻能力，从而提高皮肤适应环境能力；降低水相的凝固点，提高产品低温稳定性；防止蛋白质变性、保持各种蛋白质及多肽类活性成分的功效，对于一些无法常温与长时间保持活性的生化物质的活性有良好的保持作用；优异的保水性、吸湿性，在严重脱水时，可代替细胞中水分的作用；
烟酰胺：烟酰胺是维生素B3的一种衍生物，除了传统的美白效果之外，也被用于减少已经生成、沉淀的黑色素，阻隔其向表层细胞的转移，加速细胞新陈代谢、加快黑色素角质细胞脱落等；烟酰胺能够维持肌肤含水量，促进真皮层微循环；烟酰胺还能极大减少或消除皮肤老化现象，比如皱纹、起皮、毛孔粗大等，减少自由基对皮肤的伤害，起到预防老化、修复皮肤和减少面部暗沉的作用；
辛酰羟肟酸：辛酰羟肟酸是一种理想的有机酸，在中性pH值下具有优异的抗菌、抑菌性能，可用于不含化学防腐剂配方体系，辛酰羟肟酸是酸性到中性全程都保持没电离状态的有机酸，是最佳抑菌有机酸，有高效螯合作用，抑制霉菌需要的活性元素，限制了微生物生长所需的环境，辛酰羟肟酸和绝多数原料都有兼溶性，不受体系中表面活性剂、蛋白质等原料的影响，可以和醇类，二醇类等防腐剂复配，可以在常温和高温环境下添加，广泛用于凝胶、精华素、乳液、膏霜、洗发水、淋浴露等护肤护发品中；
三乙醇胺：三乙醇胺在化妆品配方中用于与脂肪酸中和成皂，与硫酸化脂肪酸中和成胺盐，三乙醇胺是乳膏制剂中常用乳化剂，用三乙醇胺乳化的乳膏产品具有膏体细腻，膏体亮白的特点，另外，三乙醇胺与高级脂肪酸或高级脂肪醇形成的胶体相稳定性好，产品质量稳定，可容外加成分比重高，三乙醇胺是含有卡波姆等酸性高分子凝胶的最常用中和剂，三乙醇胺通过与卡波姆等羧基中和，形成稳定的高分子结构，达到增稠和保湿的应用效果；
甘油辛酸酯：甘油辛酸酯是可用于乳液、表面活性剂产品、水醇体系的产品，有抗菌、保湿、加脂等功效，甘油辛酸酯在化妆品中作皮肤柔润剂和乳化剂使用；
积雪草提取物：积雪草提取物中含有多种三萜类，其中包含α-香树脂醇结构，主要成分为积雪草甙，羟基积雪草甙，积雪草可以紧致表皮与真皮连接部分，能使皮肤变柔软，有助于解决皮肤松弛现象，使皮肤光滑有弹性；帮助促进真皮层中胶原蛋白形成，使纤维蛋白再生，重新连接起来，从根本上消除妈妈纹，使肌肤达到紧致光滑的效果；还可帮助受损的组织愈合及紧实肌肤，既能促进表皮与真皮之间的密切连接，又能抑制脂肪细胞的增加，防止皮肤水肿、出现肥胖；
马齿笕提取物：马齿笕提取物具有在冬季防干燥老化、增加皮肤舒适度以及清除自由基，改善皮肤舒适感等的综合性能；含有植物多糖和维生素，可以营养润滑皮肤和促进上皮细胞的生理功能趋于正常，减少干燥引起的死皮和角质层的生成；含有氨基酸，可以收缩血管平滑肌，收缩作用兼有的中枢及末梢性，可以舒缓皮肤和抑制干燥引起的皮肤搔痒；含有黄酮和皂甙，可以去自由基和抗氧化、延缓皮肤衰老；含有生物碱和黄酮，可以抗菌及抑制常见致病性皮肤真菌；
燕麦仁提取物：燕麦中的燕麦酰基邻氨苯甲酸可为皮肤提供临时性的保护，并缓解由毒叶藤、槲叶毒葛、毒漆树以及蚊虫叮咬所引起的微小疼痛及瘙痒，也可缓解干燥皮肤引起的瘙痒；
小麦麸提取物：小麦麸提取物是从小麦麸皮中提取的纯天然产物，对纤维芽细胞增殖作用较好，显示有较好的活肤抗衰作用；对胶原蛋白酶的抑制和对DPPH的消除作用，含的营养成分有增强人体新陈代谢、调整神经系统功能，起到皮肤细嫩光滑，抑制、延缓皱纹产生；对B-16细胞活性有抑制，同时具有美白功效；
光果甘草根提取物：光果甘草提取物能深入皮肤内部并保持高活性，有效抑制黑色素生成过程中多种酶(如抑制酪氨酸酶)的活性，是一种快速、高效、安全、绿色的美白祛斑化妆品添加剂；
金黄洋甘菊提取物：金黄洋甘菊提取物具有抗菌抗炎作用，尤其适用于敏感皮肤；
甘草提取物：甘草为豆科植物甘草、胀果甘草或光果甘草的干燥根和根茎。甘草主要化学成分有三类：皂苷类、黄酮类及多糖类；甘草皂苷类成分主要是一系列以齐墩果烷为结构母核的化合物，如甘草酸、甘草次酸等；甘草黄酮类成分主要包括甘草苷、甘草素、异甘草苷、异甘草素等化合物，这些化合物分别属于黄酮、黄酮醇、二氢黄酮、二氢黄酮醇、查尔酮、异黄酮、二氢异黄酮、异黄烷等衍生物；甘草皂苷具有解毒、止咳平喘作用、抗炎及抗过敏作用、抗肝损伤以及降低胆固醇作用；甘草黄酮具有抑菌、抗肿瘤、抗氧化、抗心律失常等作用，主要用于制药，化妆品等；甘草多糖具有免疫调节、抗肿瘤、抗病毒等作用，主要用于制药和食品如糖果等；
虎杖根提取物：虎杖在中国和日本传统医药中被用于治疗多种病痛，其中包括霉菌感染，多种皮肤炎症，心血管疾病和肝脏疾病等，白藜芦醇和大黄素是虎杖中的主要功能成分，研究显示白藜芦醇和大黄素表现出广泛的抗氧化特性，白藜芦醇同时显示出有助于心血管健康和活血，减轻疼痛，清热去湿，去毒去痰，是一种很好的调理剂；
黄岑根提取物：既可用于医药，也可用于化妆品，是一种很好的功能性美容化妆品原料；
本发明的有益效果在于：精华液内的营养成分渗透肌肤后，被肌肤吸收，可以重现水润肌肤，配合保湿补水成分，为肌肤补充水份，舒润、修护、保湿呵护肌肤，改善肌肤缺水干燥现象，长期使用可以令肌肤玉润清透，舒缓补水，抗皱嫩肤，控油祛痘，亮泽水润。
具体实施方式
下面将结合实施例对本发明的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
实施例一：
一种补水保湿的面膜精华液，包括以下百分比的原料：甲酯0.1％、丙二醇10％、透明质酸钠7.62％、卡波姆6.5％、水55％、丁二醇7％、富勒烯5％、海藻糖3.8％、烟酰胺2.9％、辛酰羟肟酸0.1％、三乙醇胺0.08％、甘油辛酸酯0.1％、积雪草提取物0.2％、马齿笕提取物0.2％、燕麦仁提取物0.2％、小麦麸提取物0.2％、光果甘草根提取物0.2％、金黄洋甘菊提取物0.2％、甘草提取物0.2％、虎杖根提取物0.2％、黄岑根提取物0.2％。
实施例二：
一种补水保湿的面膜精华液，包括以下百分比的原料：甲酯0.56％、丙二醇8％、透明质酸钠8.12％、卡波姆8％、水50％、丁二醇6.5％、富勒烯5.67％、海藻糖4.6％、烟酰胺3.24％、辛酰羟肟酸0.5％、三乙醇胺0.05％、甘油辛酸酯0.26％、积雪草提取物0.5％、马齿笕提取物0.5％、燕麦仁提取物0.5％、小麦麸提取物0.5％、光果甘草根提取物0.5％、金黄洋甘菊提取物0.5％、甘草提取物0.5％、虎杖根提取物0.5％、黄岑根提取物0.5％。
实施例三：
一种补水保湿的面膜精华液，包括以下百分比的原料：甲酯0.3％、丙二醇11％、透明质酸钠5.07％、卡波姆5％、水63％、丁二醇5％、富勒烯4％、海藻糖3.2％、烟酰胺1.8％、辛酰羟肟酸0.3％、三乙醇胺0.13％、甘油辛酸酯0.3％、积雪草提取物0.1％、马齿笕提取物0.1％、燕麦仁提取物0.1％、小麦麸提取物0.1％、光果甘草根提取物0.1％、金黄洋甘菊提取物0.1％、甘草提取物0.1％、虎杖根提取物0.1％、黄岑根提取物0.1％。
实施例四：
一种补水保湿的面膜精华液，包括以下百分比的原料：甲酯0.2％、丙二醇9％、透明质酸钠6.34％、卡波姆7.22％、水60％、丁二醇5.4％、富勒烯4.23％、海藻糖3.0％、烟酰胺1.2％、辛酰羟肟酸0.2％、三乙醇胺0.18％、甘油辛酸酯0.33％、积雪草提取物0.3％、马齿笕提取物0.3％、燕麦仁提取物0.3％、小麦麸提取物0.3％、光果甘草根提取物0.3％、金黄洋甘菊提取物0.3％、甘草提取物0.3％、虎杖根提取物0.3％、黄岑根提取物0.3％。
一种用于生产上述补水保湿的面膜精华液的制备方法，包括如下步骤：
步骤一，按照预先设置好的重量百分比称取各原料，然后将生产用的搅拌锅清洗、消毒后晾干；
步骤二，将水、丁二醇、富勒烯、海藻糖依次加入搅拌锅内，开始搅拌加热，待其溶解完全，得到溶液一；
步骤三，将透明质酸钠、卡波姆加入步骤二得到的溶液一中，待其溶解完全，得到溶液二；
步骤四，将甲酯、丙二醇在30-35℃下混合搅拌均匀，得到溶液三；
步骤五，将步骤三得到的溶液二加热，在其温度为58-60℃时将步骤四得到的溶液三加入其中，持续升温并进行搅拌，当升温到80-85℃后开始保持恒温，30分钟后开始降温，得到溶液四；
步骤六，当溶液四温度降低到43-47℃时，将烟酰胺、辛酰羟肟酸、三乙醇胺、甘油辛酸酯、积雪草提取物、马齿笕提取物、燕麦仁提取物、小麦麸提取物、光果甘草根提取物、金黄洋甘菊提取物、甘草提取物、虎杖根提取物、黄岑根提取物加入其中，搅拌均匀，得到溶液五；
步骤七，溶液五继续降温，当温度降低到38℃时过滤出料；
步骤八，对物料进行抽样检测，检测合格后管装入洁净、无菌的储存罐中密封；
步骤九，将盛放物料的储存罐转入静置室内静置，然后进行微生物检测；
步骤十，微生物检测合格后进行无菌灌装、包装、入库。
优选的，所述步骤六中，搅拌时间不小于30分钟。
优选的，所述步骤九中，静置时间2-6h。
以上显示和描述了本发明的基本原理、主要特征和优点。本行业的技术人员应该了解，本发明不受上述实施例的限制，上述实施例和说明书中描述的只是说明本发明的原理，在不脱离本发明精神和范围的前提下，本发明还会有各种变化和改进，这些变化和改进都落入要求保护的本发明范围内。
Claims (8)
1.一种补水保湿的面膜精华液，其特征在于：包括以下百分比的原料：甲酯0.1-1％、丙二醇8-12％、透明质酸钠5-10％、卡波姆5-10％、水50-70％、丁二醇5-10％、富勒烯4-6％、海藻糖3-5％、烟酰胺1-4％、辛酰羟肟酸0.05-1％、三乙醇胺0.05-0.2％、甘油辛酸酯0.05-1％、积雪草提取物0.05-1％、马齿笕提取物0.05-1％、燕麦仁提取物0.05-1％、小麦麸提取物0.05-1％、光果甘草根提取物0.05-1％、金黄洋甘菊提取物0.05-1％、甘草提取物0.05-1％、虎杖根提取物0.05-1％、黄岑根提取物0.05-1％。
2.根据权利要求1所述的一种补水保湿的面膜精华液，其特征在于：包括以下百分比的原料：甲酯0.1％、丙二醇10％、透明质酸钠7.62％、卡波姆6.5％、水55％、丁二醇7％、富勒烯5％、海藻糖3.8％、烟酰胺2.9％、辛酰羟肟酸0.1％、三乙醇胺0.08％、甘油辛酸酯0.1％、积雪草提取物0.2％、马齿笕提取物0.2％、燕麦仁提取物0.2％、小麦麸提取物0.2％、光果甘草根提取物0.2％、金黄洋甘菊提取物0.2％、甘草提取物0.2％、虎杖根提取物0.2％、黄岑根提取物0.2％。
3.根据权利要求1所述的一种补水保湿的面膜精华液，其特征在于：包括以下百分比的原料：甲酯0.56％、丙二醇8％、透明质酸钠8.12％、卡波姆8％、水50％、丁二醇6.5％、富勒烯5.67％、海藻糖4.6％、烟酰胺3.24％、辛酰羟肟酸0.5％、三乙醇胺0.05％、甘油辛酸酯0.26％、积雪草提取物0.5％、马齿笕提取物0.5％、燕麦仁提取物0.5％、小麦麸提取物0.5％、光果甘草根提取物0.5％、金黄洋甘菊提取物0.5％、甘草提取物0.5％、虎杖根提取物0.5％、黄岑根提取物0.5％。
4.根据权利要求1所述的一种补水保湿的面膜精华液，其特征在于：包括以下百分比的原料：甲酯0.3％、丙二醇11％、透明质酸钠5.07％、卡波姆5％、水63％、丁二醇5％、富勒烯4％、海藻糖3.2％、烟酰胺1.8％、辛酰羟肟酸0.3％、三乙醇胺0.13％、甘油辛酸酯0.3％、积雪草提取物0.1％、马齿笕提取物0.1％、燕麦仁提取物0.1％、小麦麸提取物0.1％、光果甘草根提取物0.1％、金黄洋甘菊提取物0.1％、甘草提取物0.1％、虎杖根提取物0.1％、黄岑根提取物0.1％。
5.根据权利要求1所述的一种补水保湿的面膜精华液，其特征在于：包括以下百分比的原料：甲酯0.2％、丙二醇9％、透明质酸钠6.34％、卡波姆7.22％、水60％、丁二醇5.4％、富勒烯4.23％、海藻糖3.0％、烟酰胺1.2％、辛酰羟肟酸0.2％、三乙醇胺0.18％、甘油辛酸酯0.33％、积雪草提取物0.3％、马齿笕提取物0.3％、燕麦仁提取物0.3％、小麦麸提取物0.3％、光果甘草根提取物0.3％、金黄洋甘菊提取物0.3％、甘草提取物0.3％、虎杖根提取物0.3％、黄岑根提取物0.3％。
6.一种制备权利要求1-5任意一项所述的补水保湿的面膜精华液的制备方法，其特征在于：包括如下步骤：
步骤一，按照预先设置好的重量百分比称取各原料，然后将生产用的搅拌锅清洗、消毒后晾干；
步骤二，将水、丁二醇、富勒烯、海藻糖依次加入搅拌锅内，开始搅拌加热，待其溶解完全，得到溶液一；
步骤三，将透明质酸钠、卡波姆加入步骤二得到的溶液一中，待其溶解完全，得到溶液二；
步骤四，将甲酯、丙二醇在30-35℃下混合搅拌均匀，得到溶液三；
步骤五，将步骤三得到的溶液二加热，在其温度为58-60℃时将步骤四得到的溶液三加入其中，持续升温并进行搅拌，当升温到80-85℃后开始保持恒温，30分钟后开始降温，得到溶液四；
步骤六，当溶液四温度降低到43-47℃时，将烟酰胺、辛酰羟肟酸、三乙醇胺、甘油辛酸酯、积雪草提取物、马齿笕提取物、燕麦仁提取物、小麦麸提取物、光果甘草根提取物、金黄洋甘菊提取物、甘草提取物、虎杖根提取物、黄岑根提取物加入其中，搅拌均匀，得到溶液五；
步骤七，溶液五继续降温，当温度降低到38℃时过滤出料；
步骤八，对物料进行抽样检测，检测合格后管装入洁净、无菌的储存罐中密封；
步骤九，将盛放物料的储存罐转入静置室内静置，然后进行微生物检测；
步骤十，微生物检测合格后进行无菌灌装、包装、入库。
7.根据权利要求6所述的一种补水保湿的面膜精华液的制备方法，其特征在于：所述步骤六中，搅拌时间不小于30分钟。
8.根据权利要求6所述的一种补水保湿的面膜精华液的制备方法，其特征在于：所述步骤九中，静置时间2-6h。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010489049.3A CN111529468A (zh) | 2020-06-02 | 2020-06-02 | 一种补水保湿的面膜精华液及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010489049.3A CN111529468A (zh) | 2020-06-02 | 2020-06-02 | 一种补水保湿的面膜精华液及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111529468A true CN111529468A (zh) | 2020-08-14 |
Family
ID=71976127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010489049.3A Pending CN111529468A (zh) | 2020-06-02 | 2020-06-02 | 一种补水保湿的面膜精华液及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111529468A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113520953A (zh) * | 2021-08-19 | 2021-10-22 | 广东美思康宸药业股份有限公司 | 一种积雪草微精华修护保湿面膜液及其制备方法 |
| JP7492557B2 (ja) | 2022-07-27 | 2024-05-29 | 株式会社ナリス化粧品 | ふき取り化粧水用組成物 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110075017A (zh) * | 2019-04-18 | 2019-08-02 | 广州科恩生物技术有限公司 | 一种富勒烯面膜及其制备方法 |
| CN110090190A (zh) * | 2019-05-22 | 2019-08-06 | 中山爱护日用品有限公司 | 一种婴童植物舒缓清凉液及其制备方法 |
| CN110192985A (zh) * | 2019-06-26 | 2019-09-03 | 广州市百爱神生物科技有限公司 | 一种用于皮肤保湿修复的护理剂及其制备方法 |
| CN110522658A (zh) * | 2019-09-23 | 2019-12-03 | 周璇 | 一种抗敏修复组合物及其制备方法 |
-
2020
- 2020-06-02 CN CN202010489049.3A patent/CN111529468A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110075017A (zh) * | 2019-04-18 | 2019-08-02 | 广州科恩生物技术有限公司 | 一种富勒烯面膜及其制备方法 |
| CN110090190A (zh) * | 2019-05-22 | 2019-08-06 | 中山爱护日用品有限公司 | 一种婴童植物舒缓清凉液及其制备方法 |
| CN110192985A (zh) * | 2019-06-26 | 2019-09-03 | 广州市百爱神生物科技有限公司 | 一种用于皮肤保湿修复的护理剂及其制备方法 |
| CN110522658A (zh) * | 2019-09-23 | 2019-12-03 | 周璇 | 一种抗敏修复组合物及其制备方法 |
Non-Patent Citations (2)
| Title |
|---|
| 广州有绿生物科技有限公司: "《seegreen富勒烯蛋白灯泡肌面膜》", 《HTTP://FTBA.NMPA.GOV.CN:8181/FTBAN/ITOWNET/HZP_BA/FW/PZ.JSP?PROCESSID=202003021555261YFUQ&NID=202003021555261YFUQ》 * |
| 广州美颜美生物科技有限公司: "《翊彤富勒烯补水盈润修护精华》", 《HTTP://FTBA.NMPA.GOV.CN:8181/FTBAN/ITOWNET/HZP_BA/FW/PZ.JSP?PROCESSID=20191213191842EWTCZ&NID=20191213191842EWTCZ》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113520953A (zh) * | 2021-08-19 | 2021-10-22 | 广东美思康宸药业股份有限公司 | 一种积雪草微精华修护保湿面膜液及其制备方法 |
| JP7492557B2 (ja) | 2022-07-27 | 2024-05-29 | 株式会社ナリス化粧品 | ふき取り化粧水用組成物 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104173251B (zh) | 一种牦牛骨胶原肽美白面膜及其制备方法 | |
| KR101064904B1 (ko) | 천연 추출물을 포함하는 여드름 개선용 화장료 조성물 | |
| CN111388346A (zh) | 一种植物蛋白与多肽配方的冻干粉活面膜及其制备方法 | |
| CN106880563B (zh) | 一种中药美白保湿凝胶霜及其制备方法 | |
| CN109662928A (zh) | 一种具有防晒修复功效的护肤组合物及其应用和制备方法 | |
| CN104173232A (zh) | 一种提升肌肤抵抗力并修复微损肌肤的美容液制作方法 | |
| CN106539735A (zh) | 一种铁皮石斛补水亮肤面膜及其制备方法 | |
| CN104414914A (zh) | 一种妊娠纹修复精华素 | |
| CN103356425B (zh) | 剥离型人参面膜及其制备方法 | |
| CN112535652A (zh) | 一种光感赋活原液及其制备方法 | |
| CN115501143B (zh) | 一种含有雪莲培养物的抗敏舒缓组合物及其制备方法 | |
| CN111529468A (zh) | 一种补水保湿的面膜精华液及其制备方法 | |
| CN112137904A (zh) | 一种幻彩水光肌底精华液及其制备方法 | |
| CN111956573A (zh) | 一种婴儿水分霜及其制备方法 | |
| CN113797153A (zh) | 用于有效缓解皮肤过敏红血丝的组合物及制备方法与用途 | |
| CN113750007A (zh) | 一种保湿护肤的中药菊茎叶护肤系列配方及其制备方法 | |
| CN108451863A (zh) | 一种长效保湿48小时护肤精华水 | |
| CN103385824B (zh) | 剥离型丹参面膜及其制备方法 | |
| CN112402308A (zh) | 一种多效舒缓保湿水及其制备方法 | |
| CN112022795A (zh) | 皮肤护理及修复组合物、其制备方法及应用 | |
| CN111821230A (zh) | 一种防敏修复的化妆品组合物及其应用 | |
| CN110974775A (zh) | 一种含葛仙米的舒敏组合物及其制备方法和应用 | |
| KR100979143B1 (ko) | 생약추출물을 유효성분으로 함유하는 피부보습 및탄력개선용 화장료 조성물 | |
| CN113749971A (zh) | 一种具有抗衰老美白保湿护肤功能的杞丹护肤配方及其制备方法 | |
| CN110151657B (zh) | 一种含有垂盆草提取物的祛痘凝胶及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200814 |
|
| RJ01 | Rejection of invention patent application after publication |